Darrion L. Mitchell

Radiation Oncology

460 W 10th Ave
Columbus, OH 43210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Journal: bioRxiv : the preprint server for biology

Published: August 12, 2026

Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Journal: bioRxiv : the preprint server for biology

Published: August 12, 2026

Impact of Treatment Package Time on Survival in Patients with Head and Neck Adenoid Cystic Carcinoma.

Impact of Treatment Package Time on Survival in Patients with Head and Neck Adenoid Cystic Carcinoma.

Journal: Cancers

Published: January 19, 2026

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

Journal: Cancer

Published: September 05, 2025

Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.

Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 02, 2025

Circulating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.

Circulating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.

Journal: Journal of medical virology

Published: July 06, 2025

Predictors of brachial plexopathy following head and neck reirradiation.

Predictors of brachial plexopathy following head and neck reirradiation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 21, 2024

Weekly Cisplatin Cycles and Outcomes for Chemoradiation in Head and Neck Cancer.

Weekly Cisplatin Cycles and Outcomes for Chemoradiation in Head and Neck Cancer.

Journal: JAMA network open

Published: December 09, 2024

Staging and Prognosis of Nasopharyngeal Cancer: The Time for Change Is Now.

Staging and Prognosis of Nasopharyngeal Cancer: The Time for Change Is Now.

Journal: JAMA oncology

Published: October 10, 2024

Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.

Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.

Journal: International journal of cancer

Published: July 24, 2024

Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers.

Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers.

Journal: Journal of medical virology

Published: June 06, 2024

Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.

Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.

Journal: Cancer biology & therapy

Published: May 09, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026